Codes / ICD10CM / T50.A93S

T50.A93S Poisoning by other bacterial vaccines, assault, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by other bacterial vaccines, assault, sequela

Summary

This condition describes residual or late effects resulting from harmful exposure to bacterial vaccines not classified under other specific subcategories, where the exposure was due to assault. Sequela refers to complications or conditions that persist after the acute phase of the poisoning has resolved. The clinical presentation and management depend on the specific vaccine involved, the nature of the assault, and the patient's immune response during the initial event.

Causes

Exposure to other bacterial vaccines in an assault scenario may result from forced ingestion, injection, or other forms of deliberate harm. The cause is typically associated with intentional harm by another individual. Sequela arise from the residual effects of the vaccine's components or the patient's immune response to the exposure, which may manifest after the acute phase has concluded.

Risk Factors

  • History of allergic reactions to vaccine components (e.g., preservatives, adjuvants)
  • Concurrent use of immunosuppressive medications
  • Underlying immune disorders or compromised immunity
  • Prior adverse reactions to bacterial vaccines
  • Inadequate storage or handling of vaccine products

Symptoms

  • Persistent local reactions (e.g., chronic swelling, pain at exposure site)
  • Systemic symptoms (e.g., recurrent fever, malaise)
  • Allergic responses (e.g., delayed rash, urticaria)
  • Neurological symptoms (e.g., persistent dizziness, cognitive changes)
  • Gastrointestinal disturbances (e.g., chronic nausea, vomiting)

Diagnosis

Diagnosis involves reviewing the patient's history of assault-related exposure to bacterial vaccines and identifying residual effects. Clinical evaluation focuses on symptoms persisting beyond the acute phase. Laboratory tests may assess immune response or vaccine component levels, while imaging or other diagnostic tools evaluate organ function if complications are suspected.

Treatment Options

Treatment targets the specific sequela and may include managing chronic symptoms, such as pain or allergic reactions. Supportive care, medication adjustments, or specialist referrals (e.g., immunology, neurology) address ongoing issues. The approach depends on the nature of the residual effects and the patient's overall health.

Prognosis and Follow-Up

Prognosis varies based on the severity of the initial exposure and the type of sequela. Some patients may experience full recovery, while others may have persistent symptoms. Regular follow-up monitors for resolution or progression of complications, with adjustments to care as needed.

Complications

  • Chronic pain or discomfort at the exposure site
  • Persistent allergic reactions or sensitivities
  • Neurological deficits (e.g., cognitive impairment, motor dysfunction)
  • Organ damage from vaccine components
  • Psychological effects related to the assault

Lifestyle & Prevention

  • Avoidance of known vaccine allergens or triggers
  • Adherence to prescribed treatments for sequela
  • Psychological support to address trauma from the assault
  • Regular medical monitoring to detect complications early

When to Seek Professional Help

Seek immediate medical attention if new or worsening symptoms occur, such as severe allergic reactions, neurological changes, or signs of organ dysfunction. Ongoing care is necessary for managing chronic sequela and addressing related health concerns.

Tips for Medical Coders

This code is used for sequela of poisoning by other bacterial vaccines due to assault. Document the nature of the assault, the specific vaccine involved, and the residual effects. Ensure the sequela is linked to the initial poisoning event and that the code is not used for acute poisoning or other unrelated conditions.

Book a walkthrough

T50.A93S policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.